KD Logo

Moderna Inc [MRNA] Insider Hoge Stephen sells 255 Shares – Latest Insider Activity

In a filing, Moderna Inc revealed its President Hoge Stephen unloaded Company’s shares for reported $30844.0 on May 10 ’24. In the deal valued at $120.96 per share,255 shares were sold. As a result of this transaction, Hoge Stephen now holds 1,486,508 shares worth roughly $186.81 million.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

Then, AFEYAN NOUBAR sold 15,000 shares, generating $1,825,220 in total proceeds. Upon selling the shares at $121.68, the Director now owns 2,011,931 shares.

Before that, AFEYAN NOUBAR sold 15,000 shares. Moderna Inc shares valued at $1,663,855 were divested by the Director at a price of $110.92 per share. As a result of the transaction, AFEYAN NOUBAR now holds 2,026,931 shares, worth roughly $254.72 million.

HSBC Securities downgraded its Moderna Inc [MRNA] rating to a Reduce from a a Hold in a research note published on February 26, 2024; the price target was increased to $86 from $75. A number of analysts have revised their coverage, including Oppenheimer’s analysts, who increased its forecast for the stock in early January from “a Perform” to “an Outperform”. Canaccord Genuity began covering MRNA with “Hold” recommendation on November 29, 2023. HSBC Securities revised its rating on November 03, 2023. It rated MRNA as “a Hold” which previously was an “a Reduce”.

Price Performance Review of MRNA

On Monday, Moderna Inc [NASDAQ:MRNA] saw its stock jump 7.13% to $125.67. Over the last five days, the stock has gained 2.90%. Moderna Inc shares have risen nearly 26.37% since the year began. Nevertheless, the stocks have fallen -2.13% over the past one year. While a 52-week high of $142.79 was reached on 05/02/24, a 52-week low of $62.55 was recorded on 02/13/24. SMA at 50 days reached $108.03, while 200 days put it at $98.42. A total of 4.08 million shares were traded, compared to the trading of 4.24 million shares in the previous session.

Levels Of Support And Resistance For MRNA Stock

The 24-hour chart illustrates a support level at 120.84, which if violated will result in even more drops to 116.01. On the upside, there is a resistance level at 128.69. A further resistance level may holdings at 131.71. The Relative Strength Index (RSI) on the 14-day chart is 65.63, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at 4.91, which suggests price will go up in the next trading period. Percent R suggests that price movement has been bullish at 12.42%. Stochastics %K at 73.81% indicates the stock is a holding.

Most Popular